CHEST
2012
Crystalloid versus Hydroxyethyl Starch Trial
In 7,000 ICU patients, 6% HES 130/0.4 did not reduce 90-day mortality versus saline, but increased renal-replacement therapy.
Result
- Absolute difference
- 1 points
The absolute difference is derived from the event rates.
Also reported: RRT 7.0% vs 5.8% (p=0.04).
- Subtopic
- Hydroxyethyl starch
- Design
- Multicentre RCT, ANZ
- Relevance
- Practice-defining: a trial the field needs to know.
- Source
- Myburgh JA, et al. N Engl J Med. 2012;367(20):1901-1911.doi 10.1056/NEJMoa1209759
Discussion & critique
With 6S and VISEP, retired HES from ICU resuscitation worldwide.